Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

NCT03692312 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Myotonic Dystrophy

Interventions

DRUG: Tideglusib
DRUG: Placebo

Sponsor

AMO Pharma Limited